OncAlert Oral Cancer Risk Assessment System
Vigilant's OncAlert Oral Cancer Risk Assessment System is based on patented technology that detects specific protein markers known to indicate an elevated risk for oral cancer, even before the observation of visual or physical symptoms. The simple, oral rinse procedure is easy to administer and noninvasive for the patient. The test can be applied to every adult, with particular emphasis on high-risk populations (i.e, current and former tobacco users, those who consume alcohol, and people with human papillomavirus). Both the rapid point-of-care test and the lab assay that comprise the OncAlert Oral Cancer Risk Assessment System are currently under the CE Mark registration approval process and expected for release in Q2 2015.
Infographic: World Head and Neck Cancer Day
Today, July 27, marks World Head and Neck Cancer Day. This year, more than 650,000 people worldwide will be diagnosed. To raise awareness, Vigilant Biosciences , a developer of solutions that aid in the early detection and intervention of cancer, partnered with the Head and Neck Cancer Alliance, and Support for People with Oral and Head and Neck Cancer. Vigilant Biosciences created an infographic with diagnosis and survival statistics. A portion of this infographic is seen below: While the mortality statistics are disheartening at first glance, it’s important to hone in on early diagnosis,...Read More
QUESTIONS & ANSWERS